Congenital Adrenal Hyperplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia
Condition: CAH - Congenital Adrenal Hyperplasia Intervention: Drug: NBI-74788 Sponsor: Neurocrine Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2019 Category: Research Source Type: clinical trials
